Correction: RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
- DOI
- 10.1038/s41392-026-02975-z
- Published
- 2026 Aug 31
- Container
- Signal transduction and targeted therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41392-026-02975-z,
title = {Correction: RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.},
author = {Chen L and Zhang W and Chen D and Yang Q and Sun S and Dai Z and Li Z and Liang X and Chen C and Jiao Y and Zhi L and Zhao L and Zhang J and Liu X and Zhao J and Li M and Wang Y and Qi Y},
year = {2026},
journal = {Signal transduction and targeted therapy},
doi = {10.1038/s41392-026-02975-z},
url = {https://doi.org/10.1038/s41392-026-02975-z}
}RIS
TY - JOUR TI - Correction: RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis. AU - Chen L AU - Zhang W AU - Chen D AU - Yang Q AU - Sun S AU - Dai Z AU - Li Z AU - Liang X AU - Chen C AU - Jiao Y AU - Zhi L AU - Zhao L AU - Zhang J AU - Liu X AU - Zhao J AU - Li M AU - Wang Y AU - Qi Y PY - 2026 JO - Signal transduction and targeted therapy DO - 10.1038/s41392-026-02975-z UR - https://doi.org/10.1038/s41392-026-02975-z ER -
APA
L, C., W, Z., D, C., Q, Y., S, S., Z, D., Z, L., X, L., C, C., Y, J., L, Z., L, Z., J, Z., X, L., J, Z., M, L., Y, W., & Y, Q. (2026). Correction: RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-026-02975-z
Source records
- pubmed · retrieved 2026-09-26T05:10:44.635Z